Test identifies patients who benefit from targeted cancer drugs
 

The research study published at ASCO 2006 is too fresh to allow confirmation of results by other investigators.
The last link below is a comment on the subject in a message board.

http://www.european-hospital.com/en/issues/articleview.php?id=239
Test identifies patients who benefit from targeted cancer drugs (16 july 2006)

http://www.weisenthal.org/asco_06_eg...weisenthal.htm
Gefitinib-induced cell death in short term fresh tumor cultures predicts for long term patient survival in previously-treated non-small cell lung cancer (ASCO june 2006)

http://www.cancercompass.com/message-board/message/all,5580,0.htm
Message Board Discussions
Targeted, Angiogenesis Assay Development (6 june 2006)